GlassScriptPhysician profile
Mohammad Otahbachi
NPI 1184818353
$12,873.03
in general payments reported to CMS, 2019-2025
38 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $561 · 2021: $1,232 · 2022: $3,160 · 2023: $3,517 · 2024: $1,662 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,456 · Travel and Lodging: $1,401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,455.79 |
| Travel and Lodging | $1,400.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,214.01 | 2019-2025 | Eluvia, Rotapro, Watchman Flx |
| Medtronic, INC. | $2,076.60 | 2021-2025 | Hawkone, Corevalve Evolut R, Symplicity G3 |
| Penumbra, INC. | $2,035.19 | 2022-2024 | Indigo System |
| Abbott Laboratories | $1,347.91 | 2019-2025 | Esprit, Ultreon, Coroflow |
| Cardiovascular Systems INC. | $486.58 | 2019-2023 | Diamondback Coronary |
| Abiomed | $336.36 | 2023-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $332.22 | 2022-2025 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $319.44 | 2019-2020 | |
| Shockwave Medical, INC | $307.76 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $305.68 | 2019-2025 | |
| Pfizer INC. | $290.78 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $275.89 | 2020-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $245.41 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $238.89 | 2021-2023 | Xarelto |
| Stryker Corporation | $201.61 | 2025 | Artix Mt |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.68 | 2019-2025 | Lifevest |
| Lilly USA, LLC | $117.67 | 2022 | |
| Novo Nordisk INC | $103.33 | 2024-2025 | Wegovy, Ozempic |
| Inspire Medical Systems, INC. | $43.75 | 2025 | Inspire |
| Inari Medical, INC. | $43.72 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $32.06 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Ge Healthcare | $31.52 | 2022 | |
| Amgen INC. | $29.66 | 2021-2025 | Repatha |
| Scpharmaceuticals INC. | $28.33 | 2024-2025 | |
| Edwards Lifesciences Corporation | $26.56 | 2022 | |
| Cordis US Corp. | $26.08 | 2025 | Mynx Control Venous |
| Amarin Pharma, INC. | $25.38 | 2021 | |
| Esperion Therapeutics, INC. | $24.43 | 2021 | |
| Avinger INC. | $24.01 | 2022 | |
| Daiichi Sankyo INC. | $21.61 | 2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.14 | 2021 | |
| Smith+Nephew, INC. | $16.24 | 2022 | |
| Acacia Pharma INC | $14.87 | 2021 | |
| Canon Medical Systems USA, INC. | $14.79 | 2023 | Diagnostic Ultrasound System |
| Philips North America LLC | $14.79 | 2019 | |
| Surmodics, INC. | $13.59 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Sanofi-Aventis U.S. LLC | $13.25 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Otahbachi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.